Elevara Medicine
Clinical-stage biotechnology company developing innovative therapies for rheumatoid arthritis and other chronic inflammatory disorders using novel therapeutic approaches.
Investors
1
Categories
biotech, autoimmune, rheumatology, therapeutics, clinical-stage
Notes
Elevara Medicine is a clinical-stage biotechnology company focused on developing innovative therapies for rheumatoid arthritis and other chronic inflammatory disorders. The company is part of the Sofinnova Partners portfolio.
Rheumatoid arthritis and other inflammatory conditions represent significant unmet medical needs, affecting millions of patients worldwide. Despite existing treatments, many patients do not achieve adequate disease control, creating opportunities for new therapeutic approaches.
Team
- Leadership team information not publicly disclosed
Additional Research Findings
- Portfolio company of Sofinnova Partners
- Clinical-stage company
- Focus on rheumatoid arthritis and inflammatory disorders
- Developing novel therapeutic approaches
- Part of autoimmune/immunology space
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Sofinnova Partners | Paris, France | biotech-focused | seedseries-a+3 | 23 |